
Three phases of a commercial phamra market access strategy
Pre-Launch Focus on specialist drugs prescribed by doctors in a specific field, who actively seek information to make evidence-based decisions (Vakratsas and Wang, 2023). Therefore, it is crucial to facilitate specialists who gain experience through clinical studies and who share their experience with colleagues as key opinion leaders (KOLs). This can be done through presentations
